Erratum: Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo (Science Translational Medicine DOI: 10.1126/scitranslmed.aat6420)

In the Discussion of the Research Article “Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo,” one sentence was updated from “In contrast, human recombinant Abs isolated from subjects who have survived infection have the advantages to be somatically hypermutated, whereas Abs derived from immunization do not have (43)” to “In contrast, human recombinant Abs isolated from subjects who have survived infection have the advantage of being effective and naturally optimized (43).” The PDF and HTML (full text) have been corrected.